Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Kiel

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Current Drug Safety|March 10, 2010
Approaches for administering chemotherapy in the intensive care unitNicole Pitello, Michelle Treon, Kellie L Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
Observations of second primary malignancy in patients with multiple myelomaAnne Ormerod, Christopher A Fausel, Rafat Abonour, et al.
Journal of the Advanced Practitioner in Oncology|February 6, 2019
Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid LeukemiaRebecca A Myers, Scott Wirth, Sherry Williams, et al.
The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.
Drugs - Real World Outcomes|March 11, 2026
Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research ProgramPatrick J Kiel, Mark W McGiffin, Todd C Skaar, et al.
Pharmacotherapy|July 19, 2013
Experience with plerixafor for hematopoietic cell mobilization in nine patients with germ cell tumorsV J Daphne O'Hara, Alissa H Karr, Shivani Srivastava, et al.
American Journal of Therapeutics|September 25, 2013
Incidence of venous thromboembolism in the setting of hematopoietic cell transplantationV J Daphne O'Hara, Trent Miller, Rakesh Mehta, et al.
Pharmacotherapy|April 14, 2012
Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantationPatrick J Kiel, Craig A Vargo, Gourang P Patel, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 25, 2025
Educational and Equity Implications of Biomarker Testing and Targeted Therapy Access in NSCLC: Insights from the NIH All of Us Research ProgramPatrick J Kiel, Todd C Skaar, David R Foster, et al.
Journal of the American Pharmacists Association : Japha|July 22, 2020
Virtually there: An innovative approach for training oncology pharmacy residents in gynecologic oncologyKellie J Weddle, Patrick J Kiel, Brooke S Crawford, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Current Drug Safety|March 10, 2010
Approaches for administering chemotherapy in the intensive care unitNicole Pitello, Michelle Treon, Kellie L Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
Observations of second primary malignancy in patients with multiple myelomaAnne Ormerod, Christopher A Fausel, Rafat Abonour, et al.
Journal of the Advanced Practitioner in Oncology|February 6, 2019
Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid LeukemiaRebecca A Myers, Scott Wirth, Sherry Williams, et al.
The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.
Drugs - Real World Outcomes|March 11, 2026
Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research ProgramPatrick J Kiel, Mark W McGiffin, Todd C Skaar, et al.
Pharmacotherapy|July 19, 2013
Experience with plerixafor for hematopoietic cell mobilization in nine patients with germ cell tumorsV J Daphne O'Hara, Alissa H Karr, Shivani Srivastava, et al.
American Journal of Therapeutics|September 25, 2013
Incidence of venous thromboembolism in the setting of hematopoietic cell transplantationV J Daphne O'Hara, Trent Miller, Rakesh Mehta, et al.
Pharmacotherapy|April 14, 2012
Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantationPatrick J Kiel, Craig A Vargo, Gourang P Patel, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 25, 2025
Educational and Equity Implications of Biomarker Testing and Targeted Therapy Access in NSCLC: Insights from the NIH All of Us Research ProgramPatrick J Kiel, Todd C Skaar, David R Foster, et al.
Journal of the American Pharmacists Association : Japha|July 22, 2020
Virtually there: An innovative approach for training oncology pharmacy residents in gynecologic oncologyKellie J Weddle, Patrick J Kiel, Brooke S Crawford, et al.
Pageof 4